Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Ovarian cancer

Recruiting

Registered drugNo placebo

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Factor VIII deficiency+1

Recruiting

InvestigationalNo placebo

A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

InvestigationalNo placebo

Greece

Participants:18–64 years
Substances:Fidanacogene Elaparvovec

Contact Research Centre

Bladder cancer

Recruiting

Registered drugNo placebo

A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Anaemia+1

Recruiting

Registered drugNo placebo

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Elritercept

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drugNo placebo

Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin

Contact Research Centre

Lung neoplasm malignant+2

Recruiting

InvestigationalNo placebo

A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Tarlatamab

Contact Research Centre

Obesity+2

Recruiting

Investigational

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Investigational

Greece

Participants:18–64 years · 65+ years

Contact Research Centre

Obesity+2

Recruiting

Investigational

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Investigational

Greece

Participants:18–64 years · 65+ years

Contact Research Centre

Juvenile idiopathic arthritis

Recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Registered drugNo placebo

Greece

Participants:0–17 years
Substances:Filgotinib

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Asparaginase

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Find therapies in clinical trials near you – page 9

964 trials match your criteria

Ovarian cancer

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Plasma cell myeloma refractory

A study of the safety and effectiveness of REGN17372 and linvoseltamab in adults with relapsed or refractory multiple myeloma

Factor VIII deficiency+1

A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

Bladder cancer

A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

Anaemia+1

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Plasma cell myeloma refractory

Study of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma

Lung neoplasm malignant+2

A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

Obesity+2

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Obesity+2

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Juvenile idiopathic arthritis

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Acute lymphocytic leukaemia

Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Non-small cell lung cancer

Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.